MEDFX

LIVE

Serial Number

86220538

Owner

Boston Research & Development, LLC

Attorney

James David Johnson

First Use Date

Aug 15, 2013

Filing Date

Mar 13, 2014

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MEDFX Trademark

Serial Number: 86220538 • Registration: 4842066

MEDFX is a trademark filed by Boston Research & Development, LLC on March 13, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Boston Research & Development, LLC (10 trademarks)

Suite 2
90 Kerry Place, MA 02062

Entity Type: 16

Legal Representation

Attorney of Record

James David Johnson

1,331 trademarks filed View all →

Correspondence Address

James David Johnson JOHNSON & MARTIN, P.A.

500 West Cypress Creek Road

Suite 430

FORT LAUDERDALE, FL 33309

United States

Trademark Details

Filing Date

March 13, 2014

Registration Date

October 27, 2015

First Use Anywhere

August 15, 2013

First Use in Commerce

August 15, 2013

Published for Opposition

July 22, 2014

Goods & Services

Pharmaceutical and dietary preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders derived from plant extracts for therapeutical purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jul 14, 2025 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jul 14, 2025 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jul 14, 2025 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 14, 2025 APRE

TEAS SECTION 8 & 9 RECEIVED

Feb 12, 2025 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 28, 2024 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Dec 30, 2021 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Dec 30, 2021 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 29, 2021 APRE

TEAS SECTION 8 & 15 RECEIVED

Sep 27, 2021 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 27, 2020 REM1

REGISTERED-PRINCIPAL REGISTER

Oct 27, 2015 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 24, 2015 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 23, 2015 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 21, 2015 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 17, 2015 AITU

USE AMENDMENT FILED

Sep 9, 2015 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 9, 2015 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 14, 2015 EXRA

SOU EXTENSION 1 GRANTED

Mar 12, 2015 EX1G

SOU EXTENSION 1 FILED

Mar 12, 2015 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 12, 2015 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 16, 2014 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 22, 2014 NPUB

PUBLISHED FOR OPPOSITION

Jul 22, 2014 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 2, 2014 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 18, 2014 CNSA

ASSIGNED TO EXAMINER

Jun 17, 2014 DOCK

NOTICE OF PSEUDO MARK E-MAILED

Mar 28, 2014 MPMK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 27, 2014 NWOS

NEW APPLICATION ENTERED

Mar 17, 2014 NWAP

Related Trademarks

More from this Owner

CB-TEA

CBD SCIENCE

More in Same Class